Improving dementia care: The role of screening and detection of cognitive impairment

Soo Borson, Lori Frank, Peter J. Bayley, Malaz Boustani, Marge Dean, Pei Jung Lin, J. Riley McCarten, John C. Morris, David P. Salmon, Frederick A. Schmitt, Richard G. Stefanacci, Marta S. Mendiondo, Susan Peschin, Eric J. Hall, Howard Fillit, J. Wesson Ashford

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes of and treatments for cognitive impairment has converged to challenge previous thinking about screening for cognitive impairment. Consequently, changes have occurred in health care policies and priorities, including the establishment of the annual wellness visit, which requires detection of any cognitive impairment for Medicare enrollees. In response to these changes, the Alzheimer's Foundation of America and the Alzheimer's Drug Discovery Foundation convened a workgroup to review evidence for screening implementation and to evaluate the implications of routine dementia detection for health care redesign. The primary domains reviewed were consideration of the benefits, harms, and impact of cognitive screening on health care quality. In conference, the workgroup developed 10 recommendations for realizing the national policy goals of early detection as the first step in improving clinical care and ensuring proactive, patient-centered management of dementia.

Original languageEnglish
Pages (from-to)151-159
Number of pages9
JournalAlzheimer's and Dementia
Volume9
Issue number2
DOIs
StatePublished - Mar 2013

Fingerprint

Dementia
Delivery of Health Care
Health Priorities
Quality of Health Care
Drug Discovery
Medicare
Health Policy
Alzheimer Disease
Cognitive Dysfunction
Research
Therapeutics

Keywords

  • Alzheimer
  • Annual wellness visit
  • Cognitive impairment
  • Cost-benefit analysis
  • Dementia
  • Detection
  • Health care
  • Management
  • Medicare
  • Patient-centered
  • Policy
  • Priority
  • Quality
  • Screening

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Improving dementia care : The role of screening and detection of cognitive impairment. / Borson, Soo; Frank, Lori; Bayley, Peter J.; Boustani, Malaz; Dean, Marge; Lin, Pei Jung; McCarten, J. Riley; Morris, John C.; Salmon, David P.; Schmitt, Frederick A.; Stefanacci, Richard G.; Mendiondo, Marta S.; Peschin, Susan; Hall, Eric J.; Fillit, Howard; Ashford, J. Wesson.

In: Alzheimer's and Dementia, Vol. 9, No. 2, 03.2013, p. 151-159.

Research output: Contribution to journalArticle

Borson, S, Frank, L, Bayley, PJ, Boustani, M, Dean, M, Lin, PJ, McCarten, JR, Morris, JC, Salmon, DP, Schmitt, FA, Stefanacci, RG, Mendiondo, MS, Peschin, S, Hall, EJ, Fillit, H & Ashford, JW 2013, 'Improving dementia care: The role of screening and detection of cognitive impairment', Alzheimer's and Dementia, vol. 9, no. 2, pp. 151-159. https://doi.org/10.1016/j.jalz.2012.08.008
Borson, Soo ; Frank, Lori ; Bayley, Peter J. ; Boustani, Malaz ; Dean, Marge ; Lin, Pei Jung ; McCarten, J. Riley ; Morris, John C. ; Salmon, David P. ; Schmitt, Frederick A. ; Stefanacci, Richard G. ; Mendiondo, Marta S. ; Peschin, Susan ; Hall, Eric J. ; Fillit, Howard ; Ashford, J. Wesson. / Improving dementia care : The role of screening and detection of cognitive impairment. In: Alzheimer's and Dementia. 2013 ; Vol. 9, No. 2. pp. 151-159.
@article{19a9364f86ac4418ba4b04f61c0031f7,
title = "Improving dementia care: The role of screening and detection of cognitive impairment",
abstract = "The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes of and treatments for cognitive impairment has converged to challenge previous thinking about screening for cognitive impairment. Consequently, changes have occurred in health care policies and priorities, including the establishment of the annual wellness visit, which requires detection of any cognitive impairment for Medicare enrollees. In response to these changes, the Alzheimer's Foundation of America and the Alzheimer's Drug Discovery Foundation convened a workgroup to review evidence for screening implementation and to evaluate the implications of routine dementia detection for health care redesign. The primary domains reviewed were consideration of the benefits, harms, and impact of cognitive screening on health care quality. In conference, the workgroup developed 10 recommendations for realizing the national policy goals of early detection as the first step in improving clinical care and ensuring proactive, patient-centered management of dementia.",
keywords = "Alzheimer, Annual wellness visit, Cognitive impairment, Cost-benefit analysis, Dementia, Detection, Health care, Management, Medicare, Patient-centered, Policy, Priority, Quality, Screening",
author = "Soo Borson and Lori Frank and Bayley, {Peter J.} and Malaz Boustani and Marge Dean and Lin, {Pei Jung} and McCarten, {J. Riley} and Morris, {John C.} and Salmon, {David P.} and Schmitt, {Frederick A.} and Stefanacci, {Richard G.} and Mendiondo, {Marta S.} and Susan Peschin and Hall, {Eric J.} and Howard Fillit and Ashford, {J. Wesson}",
year = "2013",
month = "3",
doi = "10.1016/j.jalz.2012.08.008",
language = "English",
volume = "9",
pages = "151--159",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Improving dementia care

T2 - The role of screening and detection of cognitive impairment

AU - Borson, Soo

AU - Frank, Lori

AU - Bayley, Peter J.

AU - Boustani, Malaz

AU - Dean, Marge

AU - Lin, Pei Jung

AU - McCarten, J. Riley

AU - Morris, John C.

AU - Salmon, David P.

AU - Schmitt, Frederick A.

AU - Stefanacci, Richard G.

AU - Mendiondo, Marta S.

AU - Peschin, Susan

AU - Hall, Eric J.

AU - Fillit, Howard

AU - Ashford, J. Wesson

PY - 2013/3

Y1 - 2013/3

N2 - The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes of and treatments for cognitive impairment has converged to challenge previous thinking about screening for cognitive impairment. Consequently, changes have occurred in health care policies and priorities, including the establishment of the annual wellness visit, which requires detection of any cognitive impairment for Medicare enrollees. In response to these changes, the Alzheimer's Foundation of America and the Alzheimer's Drug Discovery Foundation convened a workgroup to review evidence for screening implementation and to evaluate the implications of routine dementia detection for health care redesign. The primary domains reviewed were consideration of the benefits, harms, and impact of cognitive screening on health care quality. In conference, the workgroup developed 10 recommendations for realizing the national policy goals of early detection as the first step in improving clinical care and ensuring proactive, patient-centered management of dementia.

AB - The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes of and treatments for cognitive impairment has converged to challenge previous thinking about screening for cognitive impairment. Consequently, changes have occurred in health care policies and priorities, including the establishment of the annual wellness visit, which requires detection of any cognitive impairment for Medicare enrollees. In response to these changes, the Alzheimer's Foundation of America and the Alzheimer's Drug Discovery Foundation convened a workgroup to review evidence for screening implementation and to evaluate the implications of routine dementia detection for health care redesign. The primary domains reviewed were consideration of the benefits, harms, and impact of cognitive screening on health care quality. In conference, the workgroup developed 10 recommendations for realizing the national policy goals of early detection as the first step in improving clinical care and ensuring proactive, patient-centered management of dementia.

KW - Alzheimer

KW - Annual wellness visit

KW - Cognitive impairment

KW - Cost-benefit analysis

KW - Dementia

KW - Detection

KW - Health care

KW - Management

KW - Medicare

KW - Patient-centered

KW - Policy

KW - Priority

KW - Quality

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84875369850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875369850&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2012.08.008

DO - 10.1016/j.jalz.2012.08.008

M3 - Article

C2 - 23375564

AN - SCOPUS:84875369850

VL - 9

SP - 151

EP - 159

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 2

ER -